Hangzhou Bio-Sincerity Pharma-Tech News

Baicheng Pharmaceutical: Announcement of Resolutions of the 20th Meeting of the Third Board of Supervisors

Oct 29 00:00

Baicheng Pharmaceutical: Announcement on the Company and its wholly-owned subsidiaries applying for comprehensive credit lines from banks and providing guarantees for wholly-owned subsidiaries

Oct 29 00:00

Baicheng Pharmaceutical: Announcement of Resolutions of the 24th Meeting of the Third Board of Directors

Oct 29 00:00

Baicheng Pharmaceutical: Announcement on changing the company\'s registered capital and amending the company\'s articles of association

Oct 29 00:00

Baicheng Pharmaceutical: Notice on Convening the First Extraordinary General Meeting of Shareholders in 2024

Oct 29 00:00

Baicheng Pharmaceutical: Report for the third quarter of 2024

Oct 29 00:00

Baicheng Pharmaceutical: Articles of Association

Oct 29 00:00

Baicheng Pharmaceutical: Announcement on the results of the ownership of the 2022 Restricted Stock Incentive Plan for the first and second reserved period and share listing

Oct 11 18:02

Baicheng Pharmaceutical: Legal Opinion of Beijing Hairun Tianrui Law Firm on the granting of price adjustments to Hangzhou Baicheng Pharmaceutical Technology Co., Ltd., the fulfillment of ownership conditions during the second vesting period, and the abolition of some restricted shares

Sep 23 17:14

Baicheng Pharmaceutical: Announcement on the 2022 Restricted Stock Incentive Plan for Cancelled Companies Partially Granted Restricted Shares Not Owned

Sep 23 17:14

Baicheng Pharmaceutical: Announcement on the achievement of the vesting conditions for the first time and the second reserved portion of the 2022 Restricted Stock Incentive Plan

Sep 23 17:14

Baicheng Pharmaceutical: Announcement of Resolutions of the 19th Meeting of the Third Board of Supervisors

Sep 23 17:14

Baicheng Pharmaceutical: Announcement of Resolutions of the 23rd Meeting of the Third Board of Directors

Sep 23 17:14

Baicheng Pharmaceutical: Independent Financial Advisory Report of Shanghai Xingong Yihe Enterprise Management Consulting Co., Ltd. on matters relating to the ownership of the first 2022 restricted stock incentive plan of Hangzhou Baicheng Pharmaceutical Technology Co., Ltd., and part of the second vesting period of the reserved grant

Sep 23 17:14

Baicheng Pharmaceutical: Announcement on Adjusting the Price Granted by the Company\'s 2022 Restricted Stock Incentive Plan

Sep 23 17:14

Baicheng Pharmaceutical: Supervisory Board\'s Review of the Vesting List for the First Time and Second Reserved Part of the 2022 Restricted Stock Incentive Plan

Sep 23 17:14

Hangzhou Bio-Sincerity Pharma-Tech: Board of directors resolution announcement.

Aug 15 00:00

Hangzhou Bio-Sincerity Pharma-Tech: Special report on the use and placement of funds raised during the first half of 2024.

Aug 15 00:00

Hangzhou Bio-Sincerity Pharma-Tech: Summary of Half-Year Report in 2024.

Aug 15 00:00

Hangzhou Bio-Sincerity Pharma-Tech: Summary table of non-operating fund use and other related fund transactions for the first half of 2024.

Aug 15 00:00